LOX and cancer: Some HIF-1α upstream regulatory molecules such as NOTCH, mTOR (mechanistic target of rapamycin) and LKB1 can also regulate LOX expression indirectly through HIF-1α and mediates cancer progression [64,65,66,67,68,69].